国信证券晨会纪要-20260121
Guoxin Securities·2026-01-21 00:57

Macro and Strategy - The macroeconomic report indicates a recovery in China's economy with a monthly GDP growth of 4.5% in December 2025, an increase of 0.4 percentage points from the previous month [6][7] - The service sector is recovering faster than industrial production, with high-tech manufacturing showing significant growth compared to traditional industries [6] - The demand side shows a structural characteristic of weak domestic demand and strong external demand, with exports remaining a crucial support for the economy [7] Industry and Company Agriculture Industry - The report highlights a bullish outlook for cattle prices, indicating a potential reversal in the beef cycle, with prices for fattened cattle at 25.66 CNY/kg, up 0.59% month-on-month and 9.38% year-on-year [11][12] - The pig market is expected to stabilize, with prices at 12.69 CNY/kg, reflecting a week-on-week increase of 1.44% [11] - The poultry sector shows mixed signals, with chicken prices slightly increasing while egg prices are under pressure due to high supply levels [11][12] Banking Industry - The banking sector is facing challenges due to an expanding gap between deposits and loans, with the gap reaching approximately 58 trillion CNY in 2025, up from about 40 trillion CNY in 2019 [16][17] - The report suggests that banks need to diversify their middle business operations to address this issue, with smaller banks focusing on wealth management and larger banks enhancing their comprehensive service capabilities [17] - The forecast for 2026 indicates a significant reduction in the decline of net interest margins, suggesting a potential recovery in the banking sector's fundamentals [18] Pharmaceutical Industry - The pharmaceutical sector is underperforming compared to the overall market, with a reported decline of 0.68% in the biopharmaceutical sector [19] - The report notes the successful IPO of Rebio Biotech, which focuses on small nucleic acid drugs, and highlights its partnerships with major pharmaceutical companies, indicating strong growth potential in this niche [19][20] Tencent Holdings - Tencent is expected to report a revenue of 194.6 billion CNY for Q4 2025, a year-on-year increase of 13%, driven by stable growth in gaming and advertising sectors [20][21] - The company is increasing its investment in AI, which is anticipated to enhance its operational capabilities and support future growth [20][23] - The gaming segment is projected to generate 58 billion CNY in revenue, with strong performances from titles like "Honor of Kings" and "Peacekeeper Elite" [21][22]

国信证券晨会纪要-20260121 - Reportify